Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23116144)

1.

Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discovery.

Song Y, Zhan P, Li X, Rai D, De Clercq E, Liu X.

Curr Med Chem. 2013 Feb 1;20(6):815-32. Review.

PMID:
23116144
2.

Designed multiple ligands: an emerging anti-HIV drug discovery paradigm.

Zhan P, Liu X.

Curr Pharm Des. 2009;15(16):1893-917. Review.

PMID:
19519431
3.

Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.

Flores A, Quesada E.

Curr Med Chem. 2013 Feb 1;20(6):751-71. Review.

PMID:
23278399
4.

Molecular strategies to design an escape-proof antiviral therapy.

Berkhout B, Sanders RW.

Antiviral Res. 2011 Oct;92(1):7-14. doi: 10.1016/j.antiviral.2011.04.002. Epub 2011 Apr 12. Review.

PMID:
21513746
5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
6.

Protein promiscuity: drug resistance and native functions--HIV-1 case.

Fernández A, Tawfik DS, Berkhout B, Sanders R, Kloczkowski A, Sen T, Jernigan B.

J Biomol Struct Dyn. 2005 Jun;22(6):615-24.

PMID:
15842167
7.

Novel compounds in preclinical/early clinical development for the treatment of HIV infections.

De Clercq E.

Rev Med Virol. 2000 Jul-Aug;10(4):255-77. Review. Erratum in: Rev Med Virol 2000 Sep-Oct;10(5):349.

PMID:
10891872
8.

The HIV-1 capsid protein as a drug target: recent advances and future prospects.

Domenech R, Neira JL.

Curr Protein Pept Sci. 2013 Dec;14(8):658-68. Review.

PMID:
24106962
9.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
10.

A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor.

Montembault M, Vo-Thanh G, Deyine A, Fargeas V, Villiéras M, Adjou A, Dubreuil D, Esquieu D, Grégoire C, Opi S, Péloponèse JM, Campbell G, Watkins J, de Mareuil J, Aubertin AM, Bailly C, Loret E, Lebreton J.

Bioorg Med Chem Lett. 2004 Mar 22;14(6):1543-6.

PMID:
15006399
11.

Current drug design of anti-HIV agents through the inhibition of C-C chemokine receptor type 5.

Speck-Planche A, Cordeiro MN.

Curr Comput Aided Drug Des. 2011 Dec;7(4):238-48. Review.

PMID:
22050678
12.

Blocking HIV entry.

Buzko OV, Shokat KM.

Nat Struct Biol. 1999 Oct;6(10):906-8.

PMID:
10504719
13.

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

Jiang S, Debnath AK.

Biochem Biophys Res Commun. 2000 Mar 24;269(3):641-6. Review.

PMID:
10720469
14.

Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.

Kazmierski WM, Kenakin TP, Gudmundsson KS.

Chem Biol Drug Des. 2006 Jan;67(1):13-26. Review.

PMID:
16492145
15.

Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop.

Andrianov AM, Anishchenko IV, Tuzikov AV.

J Chem Inf Model. 2011 Oct 24;51(10):2760-7. doi: 10.1021/ci200255t. Epub 2011 Sep 22.

PMID:
21888425
16.

Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.

Zhan P, Liu X, De Clercq E.

Curr Med Chem. 2010;17(6):495-503. Review.

PMID:
20015032
17.

Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1.

Debnath AK.

Expert Opin Investig Drugs. 2006 May;15(5):465-78. Review.

PMID:
16634685
18.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
19.

Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach.

Zhan P, Chen W, Li Z, Li X, Chen X, Tian Y, Pannecouque C, Clercq ED, Liu X.

Bioorg Med Chem. 2012 Dec 1;20(23):6795-802. doi: 10.1016/j.bmc.2012.09.058. Epub 2012 Oct 6.

PMID:
23098609
20.

LigMerge: a fast algorithm to generate models of novel potential ligands from sets of known binders.

Lindert S, Durrant JD, McCammon JA.

Chem Biol Drug Des. 2012 Sep;80(3):358-65. doi: 10.1111/j.1747-0285.2012.01414.x. Epub 2012 Jun 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk